Clinical perspectives on the value of testing for stk11 and keap1 mutations in advanced nsclc

HIGHLIGHTS

• What: In the analysis , KEAP1 mutations were identified in almost twice the proportion of patients with TMB-high than TMB-low tumors .
• Who: Cheng-Hua Jin and colleagues from the Yanbian University, China have published the research: Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC, in the Journal: (JOURNAL)

SUMMARY

Globally, lung cancer is the second most commonly diagnosed malignancy, but the leading cause of cancer mortality. The most common lung cancer subtype, non-small cell Frontiers in Oncology frontiersin.org 10.3389/fonc . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.